MACROGENICS INC's ticker is MGNX and the CUSIP is 556099109. A total of 141 filers reported holding MACROGENICS INC in Q3 2020. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $52,434 | -72.0% | 11,252 | -67.9% | 0.00% | – |
Q2 2023 | $187,582 | +20.3% | 35,062 | +50.8% | 0.00% | – |
Q4 2022 | $155,968 | +69.5% | 23,244 | -12.8% | 0.00% | – |
Q3 2022 | $92,000 | -48.0% | 26,662 | -55.6% | 0.00% | – |
Q2 2022 | $177,000 | -95.7% | 59,999 | -53.1% | 0.00% | -100.0% |
Q1 2021 | $4,073,000 | +103.2% | 127,866 | +60.7% | 0.02% | +33.3% |
Q3 2020 | $2,004,000 | +61.1% | 79,563 | +8.5% | 0.02% | +87.5% |
Q2 2019 | $1,244,000 | +204.9% | 73,311 | +270.8% | 0.01% | +300.0% |
Q2 2018 | $408,000 | -67.7% | 19,772 | -68.0% | 0.00% | -71.4% |
Q4 2016 | $1,264,000 | -76.5% | 61,827 | -65.7% | 0.01% | -77.4% |
Q3 2016 | $5,384,000 | +33.0% | 180,000 | +20.0% | 0.03% | +19.2% |
Q2 2016 | $4,049,000 | +80.0% | 150,000 | +25.0% | 0.03% | +100.0% |
Q1 2016 | $2,250,000 | -46.3% | 120,000 | -11.3% | 0.01% | -55.2% |
Q4 2015 | $4,189,000 | -67.7% | 135,271 | -77.7% | 0.03% | -69.8% |
Q3 2015 | $12,968,000 | +6104.8% | 605,431 | +10907.8% | 0.10% | +9500.0% |
Q2 2015 | $209,000 | – | 5,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cormorant Asset Management, LP | 707,978 | $21,176,000 | 2.34% |
Opaleye Management Inc. | 145,000 | $4,337,000 | 2.27% |
TIGER MANAGEMENT L.L.C. | 266,067 | $7,958,000 | 1.88% |
TANAKA CAPITAL MANAGEMENT INC | 26,170 | $783,000 | 1.88% |
BB BIOTECH AG | 1,455,000 | $43,519,000 | 1.53% |
Eventide Asset Management | 725,800 | $21,709,000 | 1.32% |
DAFNA Capital Management LLC | 54,200 | $1,621,000 | 1.13% |
Spark Investment Management LLC | 390,600 | $11,682,000 | 0.95% |
Private Capital Advisors, Inc. | 72,500 | $2,168,000 | 0.77% |
Rhenman & Partners Asset Management AB | 140,000 | $4,187,400,000 | 0.66% |